Patients on fenebrutinib had low relapse rates with data showing no active brain lesions or disability progression after nearly two…
Data presented by Delix Therapeutics at the 2025 American Society of Clinical Psychopharmacology (ASCP) Conference confirms the NeuLogiq® Platform is…
New video series explores the impact of ADHD on relationships and the role of Qelbree in helping Jay’s ADHD symptom…
NEW YORK and BERLIN, May 29, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage…
AsyncHealth has a clinician-built platform that uses AI to streamline the delivery of mental health care, increasing patient access and…
Toronto, Ontario--(Newsfile Corp. - May 28, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical…
Behavioral health providers can spend hours or days confirming if a patient is in-network, only to learn their insurance does…
Toronto, Ontario--(Newsfile Corp. - May 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn"…
PHILADELPHIA, May 27, 2025 /PRNewswire/ -- Independence Blue Cross (IBX) is closing critical gaps in care and delivering impactful results…
TEQUESTA, Fla., May 27, 2025 /PRNewswire/ -- Futures Recovery Healthcare, a leading provider of comprehensive addiction and mental health treatment,…